medigraphic.com
Instituto Nacional de Salud Pública

2019, Number 3

<< Back Next >>

salud publica mex 2019; 61 (3)

Lung cancer mortality in Mexico, 1990-2016: age-period-cohort effect

Rojas-Martínez R, Escamilla-Núñez C, Meza R, Vázquez-Salas RA, Zárate-Rojas E, Lazcano-Ponce E

Language: Spanish
References: 36
Page: 230-239
PDF size: 972.67 Kb.


ABSTRACT

Objective. To update information on the mortality trend due to lung cancer in Mexico from 1990 to 2016. Materials and methods. Age-adjusted rates were obtained using the direct method. The percentage of annual change in the mortality of lung cancer was obtained through joinpoint analysis at the national level, by region, sex and rural-urban stratum, and in the last two the age-cohort-period effect. Results. There was an annual decrease in mortality rates due to this neoplasm in the last 10 years, significantly higher in men (-3.5% CI95% -4.0,-2.9) than in women (-1.9% CI95% -2.1,-1.7), and a generational gap between men and women and urban-rural stratum with a decreasing trend in the risk of death. Conclusion. Mortality trends due to lung cancer from 1993 to 2016 show a decrease in different magnitudes and specific periods.


REFERENCES

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108. https://doi.org/10.3322/ caac.21262

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: Globocan Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. https://doi.org/10.3322/caac.21492

  3. Malvezzi M, Bosetti C, Rosso T, Bertuccio P, Chatenoud L, Levi F, et al. Lung cancer mortality in European men: trends and predictions. Lung Cancer. 2013;80(2):138-45. https://doi.org/10.1016/j.lungcan.2013.01.020

  4. Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78(3):171-8. https://doi.org/10.1016/j.lungcan.2012.08.008

  5. López-Campos JL, Ruiz-Ramos M, Fernandez E, Soriano JB. Recent lung cancer mortality trends in Europe: effect of national smoke-free legislation strengthening. Eur J Cancer Prev. 2018;27(4):269-302. https:// doi.org/10.1097/CEJ.0000000000000354

  6. Parkin DM. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer. 2011;105(suppl 2):S6-13. https://doi.org/10.1038/bjc.2011.475

  7. Borges M, Gouveia M, Costa J, Dos Santos Pinheiro L, Paulo S, Vaz Carneiro A. The burden of disease attributable to smoking in Portugal. Rev Port Pneumol. 2009;15(6):951-1004. https://doi.org/10.1016/S2173- 5115(09)70165-4

  8. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100(23):1672-94. https://doi.org/10.1093/jnci/djn389

  9. Torre L, Siegel R, Ward E, Jemal A. Global cancer incidence and mortality rates and trends–An update. Cancer Epidemiol Biomarkers Prev. 2016;25(1); 16-27. https://doi.org/10.1158/1055-9965.EPI-15-0578

  10. Torre LA, Siegel RL, Ward EM, Jemal A. International variation in lung cancer mortality rates and trends among women. Cancer Epidemiol Biomarkers Prev. 2014;23(6):1025-36. https://doi.org/10.1158/1055-9965. EPI-13-1220

  11. World Health Organization. About the WHO Framework Convention on Tobacco Control [citado junio 21, 2018]. Disponible en: http://www. who.int/fctc/about/en/

  12. Malvezzi M, Bosetti C, Chatenoud L, Rodríguez T, Levi F, Negri E, et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol. 2004;15(11):1712-8. https://doi.org/10.1093/annonc/mdh424

  13. Lazcano-Ponce EC, Tovar-Guzman V, Meneses-Gonzalez F, Rascon-Pacheco RA, Hernandez-Avila M. Trends of lung cancer mortality in Mexico. Arch Med Res. 1997;28(4):565-70.

  14. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. 2a ed. Cuernavaca, México: Instituto Nacional de Salud Pública, 2013.

  15. Dirección General de Información en Salud. Cubos Dinámicos-Defunciones (Mortalidad). México: Secretaría de Salud, 2018. [citado junio 21, 2018]. Disponible en: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/ bdc_poblacion_gobmx.html

  16. Consejo Nacional de Población. Proyecciones de la población de México, 1990-2010, 2010-2050. México: Conapo, 2018. [citado junio 21, 2018]. Disponible en: http://www.conapo.gob.mx/es/CONAPO/Proyecciones

  17. Instituto Nacional de Estadística y Geografía. Síntesis metodológica del XII Censo General de Población y Vivienda 2000. Ciudad de México: INEGI, 2003 [citado octubre 15, 2018]. Disponible en: http://www.beta. inegi.org.mx/app/biblioteca/ficha.html?upc=702825000014

  18. Instituto Nacional de Estadística y Geografía. Serie histórica censal e intercensal (1990-2010). Ciudad de México: INEGI, 2018 [citado junio 21, 2018]. Disponible en: https://www.inegi.org.mx/programas/ccpv/cpvsh/

  19. Pagano M, Gauvreau K. Fundamentos de Bioestadística. 2a ed. Ciudad de México: Thomson Learning, 2001.

  20. Instituto Nacional de Estadística y Geografía. XII Censo General de Población y Vivienda 2000. Ciudad de México: INEGI, 2003 [citado junio 11, 2018]. Disponible en: https://www.inegi.org.mx/programas/ccpv/2000/

  21. Kim H, Fay M, Feuer E, Midthune D. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335- 51. https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AIDSIM336> 3.0.CO;2-Z

  22. Holford TR. The Estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39(2):311-24. https://doi.org/10.2307/2531004

  23. Surveillance Research. Joinpoint Regression Program. Cancer control and population sciences. 2013; Version 4.0.4. [citado octubre 20, 2014]. Disponible en: http://surveillance.cancer.gov/joinpoint/

  24. Organización Mundial de la Salud. Informe OMS sobre la epidemia mundial de tabaquismo, 2015. Resumen [citado julio 11, 2018]. Disponible en: http://www.who.int/tobacco/global_report/2015/summary/es/

  25. Reynales LM, Lazcano E. Nuevos retos para el control del tabaquismo en México y las américas: estrategias contra la interferencia de la industria tabacalera. Salud Publica Mex. 2012; 54(3):201-2. https://doi.org/10.1590/ S0036-36342012000300001

  26. Reynales-Shigematsu LM. Tobacco and cancer: Epidemiology and new perspectives of prevention and monitoring in Mexico. Salud Publica Mex. 2016;58(2):251-60. https://doi.org/10.21149/spm.v58i2.7794

  27. Bray F, Piñeros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Publica Mex. 2016;58(2):104-17. https://doi.org/10.21149/spm.v58i2.7779

  28. Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, et al. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58(2):118-31. https://doi.org/10.21149/spm.v58i2.7780

  29. González-León M, Fernández-Gárate JE, Rascón-Pacheco RA, Valladares-Aranda MA, Dávila-Torres J, Borja-Aburto VH. The burden of disease of cancer in the Mexican Social Security Institute. Salud Publica Mex. 2016;58(2):132-41. https://doi.org/10.21149/spm.v58i2.7781

  30. Hernández-Ávila JE, Palacio-Mejía LS, González-González L, Morales- Carmona E, Espín-Arellano LI, Fernández-Niño JA, et al. Utilization of hospital services for cancer care in Mexico. Salud Publica Mex. 2016;58(2):142-52. https://doi.org/10.21149/spm.v58i2.7783

  31. Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for lung cancer: US preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330-8. https://doi.org/10.7326/ M13-2771

  32. Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 2012;104(7):541-8. https://doi.org/10.1093/jnci/djs136

  33. Reynales-Shigematsu LM, Barrientos-Gutiérrez I, Zavala-Arciniega L, Arillo-Santillán E. Nuevos productos de tabaco, una amenaza para el control de tabaco y la salud pública de México. Salud Publica Mex. 2018;60(5):598-604. https://doi.org/10.21149/9682

  34. Morello P, Pérez A, Braun SN, Thrasher JF, Barrientos I, Arillo-Santillán E, Mejía R. Smoking susceptibility as a predictive measure of cigarette and e-cigarette use among early adolescents. Salud Publica Mex. 2018;60(4):423-31. https://doi.org/10.21149/9193

  35. Blanco A, Sandoval R, Martínez-López L, Caixeta R. Diez años del Convenio Marco de la Organización Mundial de la Salud para el Control del Tabaco: avances en las Américas. Salud Publica Mex. 2017;59(supl 1):S117-25. https://doi.org/10.21149/8682

  36. Hambleton IR, Jeyaseelan SM, Howitt C, Hennis AJ. Monitoring Caribbean tobacco use: baseline adolescent smoking prevalence and regional disparities. Salud Publica Mex. 2017;59(suppl 1):S12-21. https:// doi.org/10.21149/7849




2020     |     www.medigraphic.com